XCELLA BIOSCIENCES
XCella Biosciences is an antibody discovery company that offers a platform that can screen single B cells. It develops therapeutics to transform patient outcomes with protein engineering and disruptive technology. xCella's xPloration is an integrated hardware and software platform that enables high dimensional measurement and analysis of genotype, phenotype, and cellular functions at the single-cell level, millions of cells at a time. The company was founded in 2015 and based in Menlo Park, California.
XCELLA BIOSCIENCES
Industry:
Biotechnology Life Science Therapeutics Wellness
Founded:
2015-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.xcellabio.com
Total Employee:
1+
Status:
Active
Contact:
(650) 461 - 4503
Email Addresses:
[email protected]
Technology used in webpage:
SPF Euro Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS Cloudflare Hosting Cloudflare DNS
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Signum Biosciences
Signum Biosciences develops small molecule therapeutics derived from its STM platform to modulate signal transduction imbalances.
Founder
Official Site Inspections
http://www.xcellabio.com
- Host name: 104.21.64.1
- IP address: 104.21.64.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "xCella Biosciences"
xCella Biosciences - Crunchbase Company Profile
Organization. xCella Biosciences . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Contact Email …See details»
xCella Biosciences Company Profile 2024: Valuation, …
XCella Biosciences General Information Description. Developer of protein engineering and disruptive technology therapeutics intended to transform …See details»
xCella Biosciences - Craft
XCella Biosciences is a company engaged in protein drug discovery. It builds a pipeline of protein therapeutics, including XC-201, a clinic ready asset that directs T cell-mediated …See details»
xCella Biosciences - Ownership and Business Overview - Mergr
Www.xcellabio.com. Profile Investors (1) Analytics xCella Biosciences is an antibody discovery company. xCella's xPloration™ platform is a proprietary microcapillary platform that can …See details»
xCella Biosciences, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore xCella Biosciences, Inc. with its drug pipeline, therapeutic area, technology platform, 2 news, Disease Domain:Neoplasms, Technology Platform:Fusion protein ...See details»
Xcella Biosciences, Inc. | (650) 461-4503 | Menlo Park, California
Web: www.xcellabio.com. Edit: Edit or Remove. Business Description. Xcella Biosciences, Inc. is located in Menlo Park, California, and was founded in 2015. At this location, Xcella …See details»
xCella Biosciences Overview | SignalHire Company Profile
XCella Biosciences is a private company that has been in the industry for 6 years. The company currently specializes in the Biotechnology, Biotechnology, Medical Research & Laboratories …See details»
Company Information - RocketReach
XCella is developing and applying a novel protein analysis and engineering technology platform for discovery of new drugs and industrial products.See details»
xCella Biosciences Company Overview, Contact Details
Learn more about xCella Biosciences's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
xCella Biosciences - Products, Competitors, Financials, Employees ...
XCella Biosciences is developing and applying protein analysis and engineering technology platforms for discovery of new drugs and industrial products. On September 10th, 2020, xCella …See details»
xCella Biosciences - VentureRadar
XCella Biosciences VentureRadar profile. Find out more about xCella Biosciences, Biologics.See details»
xCella - Overview, News & Similar companies | ZoomInfo.com
Apr 8, 2019 www.xcellabio.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. Ligand Expands OmniAb® Antibody Discovery …See details»
xCella Biosciences acquired by Ligand Pharmaceuticals - Crunchbase
Acquired Organization: xCella Biosciences XCella Biosciences is an antibody discovery company that offers a platform that can screen single B cells. Acquiring Organization: Ligand …See details»
xCella Biosciences, Inc. | CipherBio
Explore xCella Biosciences, Inc.'s investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
xCella - Company Profile - Tracxn
XCella - Developer of immuno-oncology antibody therapeutics. Raised funding from 1 investor. Founded by Bob Chen in the year 2016. xCella has 3154 competitors.See details»
xCella Announces New Antibody Development Program
Apr 9, 2019 For more about xCella, please visit www.xcellabio.com or email [email protected]. Contacts. xCella Biosciences, Inc. Jennifer Cochran, PhD Co-founder and Executive …See details»
TEAM - Xcellbio
Prev: Lawrence Berkeley National Lab, Harvard Medical School, The Scripps Research InstituteSee details»
Ligand Expands OmniAb Antibody Discovery Platform Through the ...
Sep 10, 2020 The acquired technologies continue to position Ligand’s OmniAb as a best-in-class platform for antibody discovery. SAN DIEGO–(BUSINESS WIRE)– Ligand …See details»
xcellbio - Products, Competitors, Financials, Employees, …
The companies are combining to establish a single organization uniquely positioned to drive future technology breakthroughs and respond to researchers’ desire for unified solutions in spatial …See details»
ExcellaBio - Products, Competitors, Financials, Employees, …
ExcellaBio has developed technologies including an exosome-like membrane nanostructure (Bioxome) and related processes for the production of exosomes/extracellular vesicles (EVs). …See details»